DEA schedule
Is norethindrone a controlled substance?
Federal schedule for norethindrone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Norethindrone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and norethindrone is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted norethindrone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 18 prescription listings from 12 labelers, none with a DEA schedule |
| DEA controlled substances list | norethindrone is not on the list |
Norethindrone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 79929-015 | Affodel | tablet | .35 mg/1 | Naari Pte. Limited | None |
| 75907-074 | CAMILA | tablet | .35 mg/1 | Dr. Reddy's Labratories Inc. | None |
| 59651-136 | Emzahh | tablet | .35 mg/1 | Aurobindo Pharma Limited | None |
| 71205-526 | ERRIN | tablet | .35 mg/1 | Proficient Rx LP | None |
| 75907-075 | ERRIN | tablet | .35 mg/1 | Dr. Reddy's Labratories Inc. | None |
| 68462-303 | HEATHER | tablet | .35 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 65862-925 | Incassia | tablet | .35 mg/1 | Aurobindo Pharma Limited | None |
| 68180-877 | Jencycla | tablet | .35 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 50102-300 | Lyleq | tablet | .35 mg/1 | Afaxys Pharma, LLC | None |
| 70700-317 | MELEYA | tablet | .35 mg/1 | Xiromed LLC | None |
| 0480-3475 | Nora BE | tablet | .35 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 0378-7292 | NORETHINDRONE | tablet | .35 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 50090-6161 | NORETHINDRONE | tablet | .35 mg/1 | A-S Medication Solutions | None |
| 63187-748 | Norethindrone | tablet | .35 mg/1 | Proficient Rx LP | None |
| 68180-876 | NORETHINDRONE | tablet | .35 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 68462-305 | Norethindrone | tablet | .35 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 82804-175 | NORETHINDRONE | tablet | .35 mg/1 | Proficient Rx LP | None |
| 70700-316 | Orquidea | tablet | .35 mg/1 | Xiromed, LLC | None |
Questions
Is norethindrone a controlled substance?
No. Norethindrone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and norethindrone is not on the DEA controlled substances list.
Is norethindrone a narcotic?
No. Norethindrone is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Progestin.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.